OnKure Therapeutics (OKUR) Earnings Date & Reports

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

OKUR is expected to report earnings to fall 94.12% to -7 cents per share on November 06

OnKure Therapeutics OKUR Stock Earnings Reports

Q3'24

Est.

$-0.07

Q1'25

Missed

by $0.63

Q4'24

Missed

by $1.30

The last earnings report on May 06 showed earnings per share of -119 cents, missing the estimate of -56 cents. With 165.87K shares outstanding, the current market capitalization sits at 35.80M.

View a ticker or compare two or three

Compare

OKUR